MindImmune Therapeutics

MindImmune Therapeutics Inc

Biotech & Life Sciences

Sector

Seed

Stage

Biotech

Model

01Company Overview

MindImmune Therapeutics Inc. is a drug discovery company pioneering a new approach to treat Alzheimer’s disease and other neuro-degenerative conditions by targeting the immune drivers of these diseases.

02Backed By1 investor

DFDolby Family Ventures→

03Recent Activity

Is this your company? Claim your profile

FROM Dolby Family Ventures

MindImmune extended its Series A to $30M to advance its inflammation-focused Alzheimer's therapy into the clinic and appointed Isaac Stoner as CEO.

INVESTMENT·businesswire.com

NOV 24, 2025

04Similar Companies

AT

Acionna Therapeutics

Biotech & Life Sciences

→

AL

AstronauTX Ltd

Biotech & Life Sciences

→

TB

Therini Bio

Biotech & Life Sciences

→

T

TrueBinding

Biotech & Life Sciences

→

AP

Acumen Pharmaceuticals

Biotech & Life Sciences

→

05Startup DNA

9

signals

Sectors
Business Model
Technology